4 transcripts
BMY
Earnings call transcript
NYSE
2024 Q2
26 Jul 24
. Sequentially, global sales were up driven by demand and an estimated benefit of $65 million related to customer buying patterns in the U.S. We expect growth
BMY
Earnings call transcript
NYSE
2024 Q1
25 Apr 24
that's where that took place.
And now with KarMMa-3, it gives us the opportunity to have a different conversation with our customers about our data
BMY
Earnings call transcript
NYSE
2023 Q4
2 Feb 24
remain focused on demonstrating the benefits of the product profile to our customers' anticipation of expanded use in the U.S. upon the potential
BMY
Earnings call transcript
NYSE
2023 Q2
27 Jul 23
versus last year, driven by demand in first-line lung, gastric and adjuvant bladder cancer indications, offset by customer buying patterns
- Prev
- 1
- Next